fatetherapeutics.com (FATE) - Company Cash Volume

Official company branding of Fate Therapeutics, Inc. (FATE)

Cash on hand indicates a lack of profitability, as Fate Therapeutics, Inc. (FATE) relies on external funding. The company focuses on developing stem cell-based cancer therapies in the US, leveraging its own scientific capabilities. The value of 0.14 reflects the latest liquidity level supporting automated iPSC cloning platforms, which eliminate manual labor in the mass production of drugs.

FATE - Fate Therapeutics Corp Company Cash Reserve over the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Fate Therapeutics, Inc.

Fundamental company valuation:Fate Therapeutics Inc
Brand item of Fate Therapeutics

This indicator measures the volume of liquid assets, determining the business's ability to fund expansion without resorting to expensive debt capital. The trend is driven by the difference between operating cash flow and capital expenditures. By analyzing the cash on hand for Fate Therapeutics, Inc. (FATE) at the level of 0.14, an investor assesses the resource base for scaling iPSC technologies. Sufficient liquidity ensures Fate Therapeutics, Inc. (FATE) maintains leadership in cancer therapy production and future pricing power.

Competitors of Fate Therapeutics, Inc. (FATE)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds